Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Treating Cardiovascular Disease




for Members

Resolving Inflammation to Treat Cardiovascular Disease

Monday, April 27, 2020, 11:30 AM - 12:45 PM EDT

The New York Academy of Sciences
115 Broadway, 7th Floor, New York City, 10006 USA

Presented By

The New York Academy of Sciences


Every year in the United States, more than 1.5 million people will suffer from either a heart attack or a stroke. This 75 minute webinar will explore the links between chronic inflammation and these conditions and discuss how strategies to resolve inflammation could lead to new therapies.

In This Webinar, You'll Learn

  • About recent clinical data linking chronic inflammation to cardiovascular disease, the leading cause of heart attack and stroke;
  • How failure to resolve chronic inflammation promotes the development of atherosclerotic cardiovascular disease;
  • New approaches that modulate the resolution of inflammation and have the potential to provide improved treatments for this widespread condition.
Resolving Inflammation to Treat Cardiovascular Disease

Paul Ridker, MD, MPH
Harvard Medical School

Dr. Paul M. Ridker is director of the Center for Cardiovascular Disease Prevention at Brigham and Women’s Hospital (BWH) and the Eugene Braunwald Professor of Medicine at Harvard School of Medicine (HMS). He received his medical degree from HMS and then completed an internal medicine residency and a cardiology fellowship at BWH. Dr. Ridker’s primary research focus has involved inflammatory mediators of heart disease and the molecular and genetic epidemiology of hemostasis and thrombosis, with particular interests in biomarkers for coronary disease, “predictive” medicine, and the underlying causes and prevention of atherosclerotic disease.

Gabrielle Fredman

Gabrielle Fredman, PhD
Albany Medical College

Gabrielle Fredman received a PhD from Boston University in 2009. She pursued post-doctoral fellowships at Harvard Medical School and Columbia University studying the chemical biology of lipid mediators in the resolution of inflammation with a focus on their actions in atherosclerosis. Dr. Fredman was a recipient of the Young Investigator Award from the Eicosanoid Research Foundation and a finalist for the Irvine Page Award in 2016. She is now an Associate Professor at Albany Medical College.  Her research interests include uncovering mechanisms associated with defective resolution of inflammation in atherosclerosis and aging.

Access to Webinar Materials

A link to the eBriefing (video recording) of this Webinar will be available to all registrants within 30 days of the event date.  The eBriefing will be available to all registrants for 60 days following publication, after which it will revert to Member-only access. Not a Member? Join today.